BioPhy, a healthcare fintech, uses AI to quantify risk and predict outcomes in drug development.
Location
Philadelphia, PA, US
Founded
2019
BioPhy is a healthcare fintech company that leverages artificial intelligence to accelerate and improve drug development. Their patent-pending AI technology is designed to bring predictability and quantifiable risk assessment to the pharmaceutical industry. BioPhy's platform is versatile, applicable at various stages from pre-clinical research through regulatory approval and beyond.
The company's solutions-led platform utilizes robust data and world-renowned AI expertise to drive unprecedented speed and value for clients ranging from early-stage biotech to large pharmaceutical companies. BioPhy's technology offers proven accuracy and significant improvements in speed and efficiency, processing clinical trials daily to support portfolio growth in drug development.
BioPhy - Classification
NAICS
513200Software Publishers
510000Information
513000Publishing Industries
513210Software Publishers
SIC
7300Business Services
7370Computer Programming, Data Processing, And Other Computer Related